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ABSTRACT
Objectives Our aim was to determine clusters of non- 
communicable diseases (NCDs) in a very large, population- 
based sample of middle- aged and older adults from 
low- and middle- income (LMICs) and high- income (HICs) 
regions. Additionally, we explored the associations with 
several covariates.
Design The total sample was 72 140 people aged 50+ 
years from three population- based studies (English 
Longitudinal Study of Ageing, Survey of Health, Ageing and 
Retirement in Europe Study and Study on Global Ageing 
and Adult Health) included in the Ageing Trajectories of 
Health: Longitudinal Opportunities and Synergies (ATHLOS) 
project and representing eight regions with LMICs and 
HICs. Variables were previously harmonised using an 
ex- post strategy. Eight NCDs were used in latent class 
analysis. Multinomial models were made to calculate 
associations with covariates. All the analyses were 
stratified by age (50–64 and 65+ years old).
Results Three clusters were identified: ‘cardio- metabolic’ 
(8.93% in participants aged 50–64 years and 27.22% 
in those aged 65+ years), ‘respiratory- mental- articular’ 
(3.91% and 5.27%) and ‘healthy’ (87.16% and 67.51%). 
In the younger group, Russia presented the highest 
prevalence of the ‘cardio- metabolic’ group (18.8%) and 
England the ‘respiratory- mental- articular’ (5.1%). In the 
older group, Russia had the highest proportion of both 
classes (48.3% and 9%). Both the younger and older 
African participants presented the highest proportion of 
the ‘healthy’ class. Older age, being woman, widowed and 
with low levels of education and income were related to 
an increased risk of multimorbidity. Physical activity was 
a protective factor in both age groups and smoking a risk 
factor for the ‘respiratory- mental- articular’.
Conclusion Multimorbidity is common worldwide, 
especially in HICs and Russia. Health policies in each 
country addressing coordination and support are needed to 
face the complexity of a pattern of growing multimorbidity.
BACKGROUND
By 2050, the population aged 60 years 
and older is expected to reach 2 billion 
worldwide compared with 900 million in 
2015.1 Along with this rapid increase, the 
incidence of chronic conditions (CCs) or 
non- communicable diseases (NCDs) is also 
on the rise, having become the leading cause 
of morbidity and disability worldwide.2
Multimorbidity, defined as the co- existence 
of two or more CCs, is more common in older 
adults and is often more prevalent in people 
of lower socioeconomic status.3 Multimor-
bidity is thought to account for 65% of total 
healthcare expenses in high- income coun-
tries (HICs) because of the huge associated 
healthcare utilisation.4 Due to the increasing 
prevalence of multimorbidity, the managing 
of multiple conditions has become an 
unavoidable international research priority 
because of the high impact on the quality of 
life of patients and caregivers and on health-
care systems.3
Most studies on the prevalence of multi-
morbidity in older people come from HICs, 
while data from middle- aged adults and 
Strengths and limitations of this study
 ► This study used a large, harmonised, multiregion-
al database, which allowed us to compare two age 
groups as well as disease prevalence in regions with 
differing incomes.
 ► The presence or absence of the non- communicable 
diseases was based on self- reported measures, and 
thus might be affected by measurement errors or 
lack of accuracy.
 ► Only common diseases across studies were includ-
ed in the analyses, so this might have led to a small-
er number of latent classes or to different clusters.
 ► When performing latent class analysis, we forced 
the solution as we aimed to do comparisons among 
age subsamples and regions in terms of disease 
prevalence as well as protective and risk factors.
 ► The use of multiple imputations for missing data in 
the covariates could carry some bias.
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low- and middle- income countries (LMICs) are much 
more limited.5–8 LMICs are experiencing an increase in 
life expectancy that, together with changes in lifestyle and 
environment exposures, is triggering changes in their 
disease burden profile.3 9 Few studies have compared 
patterns of multimorbidity between HICs and LMICs. 
Afshar et al10 used population- based chronic disease data 
from the World Health Survey to compare multimorbidity 
prevalence across 27 LMICs and 1 HIC and used gross 
domestic product (GDP) to study intercountry socio-
economic differences. They found high multimorbidity 
prevalence in all countries and a positive but non- linear 
relationship between country GDP and multimorbidity 
prevalence, suggesting the influence of other factors, 
such as lifestyles, social conditions and differences across 
health systems. Four latent classes were identified in a 
cross- sectional sample of Australian seniors aged 50 years 
and over, using self- reported diagnosis of 11 conditions, 
including cancer and Parkinson’s disease.11 Another 
study, focusing on complex healthcare needs of Italian 
elderly people, found five clusters using 15 diseases.12 A 
study conducted in a sample of 162 283 people from a 
survey of Danish population identified seven latent classes 
considering 15 chronic diseases and seven age groups, 
ranging from 16 to 104 years.13 These differences could 
be explained in light of variations in collection methods, 
data sources, populations, diseases included and the anal-
ysis performed.11 14 15
Similarly, the lack of study of differences in multi-
morbidity between HICs and LMICs may be due to the 
use of different methodologies, which might hinder 
comparisons of prevalence and multimorbidity patterns 
across countries. The integration of data from different 
studies would allow us to determine differences across 
regions and cohorts, as well as to explore risk and protec-
tive factors involved in the clustering of CCs, thereby 
improving our understanding of the problem and the 
creation of adapted medical guidelines.
This study aimed to (a) identify multimorbidity clusters 
in middle- aged (50–64 years) and older adults (+65 years) 
from different regions, classified as LMICs and HICs; 
(b) investigate the associations between multimorbidity 
clusters and sociodemographic, economic, lifestyles and 
health status variables and (c) explore differences across 
regions.
METHODS
Study design and data extraction
The present study used data from the Ageing Trajecto-
ries of Health: Longitudinal Opportunities and Synergies 
(ATHLOS) project.16 Longitudinal data from 17 interna-
tional cohort studies related to health and ageing were 
harmonised with the aim of obtaining an integrated 
dataset and achieving a better understanding of ageing 
and health processes.
We selected three studies due to their inclusion of the 
variables of interest and the possibility of comparing 
HICs and LMICs. Baseline samples of the following 
studies were included in the analyses: the WHO’s Study 
on Global Ageing and Adult Health (SAGE),17 the 
English Longitudinal Study of Ageing (ELSA)18 and the 
Survey of Health, Ageing and Retirement in Europe 
Study (SHARE).19 These panel studies included non- 
institutionalised people aged 50 years and older. SAGE 
comprises six LMICs according to The World Bank Clas-
sification,20 namely Ghana, South Africa, Mexico, India, 
China and Russia; ELSA includes the English population 
and SHARE covers 11 countries of the European Union 
and Israel at baseline, considered as HICs.20
The analyses presented focused on people aged 50 
years and older who were part of the core sample of each 
study and who completed a non- proxy interview at base-
line. We excluded from the analyses those participants 
who participated via proxy due to cognitive problems or 
severe physical limitations. Moreover, people with missing 
values in sex and age were excluded, resulting in a final 
sample of 72 140 individuals. Mexico was excluded from 
the analyses due the high percentage of missingness in 
the variables of interest (see online additional file 1: table 
S1).
Patient and public involvement
No patient involved.
Variables
The following variables were the result of a stringent, 
ex- post harmonisation process using systematic harmoni-
sation methodology and tools from Maelstrom Research.21
Eight NCDs were used to conduct the analysis, including 
those that were available in the three studies: diabetes, 
hypertension, asthma, chronic lung disease, joint disor-
ders (arthritis, rheumatism or osteoarthritis), angina or 
myocardial infarction, stroke and depression. The pres-
ence or absence of these conditions was self- reported and 
based on a medical diagnosis. Depression was assessed 
with standardised tools, such as the Composite Interna-
tional Diagnostic Interview (CIDI) in the SAGE study, 
the Center for Epidemiologic Studies Depression Scale 
(CES- D) in ELSA and the EURO- D in SHARE.22–24 A 
dichotomous variable (yes/no) was created using the 
indicated cut- off score for each tool and population based 
on previous studies.22 25 26
Self- reported demographic variables included age, 
sex, level of education (primary or less, secondary and 
tertiary), marital status (single, married or currently 
cohabiting, separated or divorced, and widowed) and 
quintiles of household wealth (first quintile indicating 
lowest level). Lifestyles and health behaviours were ‘ever 
smoked’ any type of tobacco and physical activity refer-
ring to the practice of vigorous exercise during the last 
2 weeks, both coded as yes or no. Other health- related vari-
ables were self- rated health (good, moderate or poor), 
presence or absence of loneliness feelings in the last 
week, difficulties in activities of daily living (ADL), cogni-
tive performance and number of diseases.
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To assess difficulties in ADL, we used a set of daily self- 
care activities, which were common across studies, such 
as problems in using the toilet, bathing or showering, 
getting dressed, eating, moving, or getting in or out of 
bed. Each of the ADL difficulties was coded into a yes/no 
if the person answered ‘severe’ or ‘extreme/cannot do 
it’. To build the set of ADL difficulties, we coded yes if 
the person reported at least one difficulty in any of the 
six items.
Immediate and delayed recall was assessed using the 
10- word learning list task and verbal fluency utilising the 
animal naming test.27 Continuous total scores were used 
to perform the analyses. Number of diseases was built by 
adding up the occurrences of all the above- mentioned 
NCDs.
Finally, a seven- level regional membership variable was 
created in order to analyse regional differences, based 
on the WHO and the United Nations Statistical Division 
(UNSD) regional classification.28 29 Moreover, the World 
Bank Classification was used to classify these regions into 
HICs or LMICs.20 SAGE includes Africa (Ghana and 
South Africa), China and India, all of them considered 
as LMICs. SHARE countries were grouped into three 
regions: Northern Europe (Denmark, Sweden), Southern 
Europe (Greece, Italy and Spain) and Western Europe 
(Austria, Belgium, France, Germany, Israel, Netherlands 
and Switzerland). ELSA and SHARE regions were consid-
ered as HICs. Ghana and South Africa were grouped 
together and named as Africa for practical purposes as 
well as due to their smaller sample size. These countries 
are not necessarily representative of the whole continent.
Statistical analysis
All the analyses were performed using data from the base-
line. Descriptive statistics were used to summarise infor-
mation regarding sociodemographic economic variables 
and disease prevalence among regions. CIs (95% CI) 
were calculated for categorical variables in order to make 
comparisons across regions.
Latent class analysis (LCA) was conducted stratified 
by age (50–64, +65 years). Eight NCDs (diabetes, hyper-
tension, asthma, chronic lung disease, joint disorders, 
angina–myocardial infarction, stroke and depression) 
were used as observed indicators without using covari-
ates since we aimed to identify latent classes only based 
on disease variables. Region was used as cluster when 
conducting LCA in order to accurately describe disease 
proportions, indicating that the subjects were not inde-
pendent random draws, but rather were nested within 
clusters.30
The optimal number of latent classes was determined 
using the adjusted Bayesian Information Criterion (aBIC), 
the consistent Akaike Information Criterion (CAIC) and 
the Entropy Index. Lower values of aBIC and CAIC indi-
cate better fit, whereas Entropy Index values higher than 
0.80 indicate that the latent classes are highly discrimi-
nating.31 The average posterior probability indicates how 
well a model classifies individuals into their most likely 
class. Values higher than 0.70 indicate well- identified 
classes.32 Additionally, interpretability and clinical judge-
ment were used.32 33
Missing data in one of the indicators were handled with 
the full information maximum likelihood technique, 
assuming missing- at- random (MAR).34 Missing data in 
the covariates were handled using multiple imputation 
by chained equations assuming MAR.34 The imputation 
model included the outcome (group membership in 
one of the latent classes) and all the variables used in 
the regression models. In the online additional file 1: 
table S2-10, there is a report of those variables and the 
percentage of missingness of each region in the variables 
of interest.
Adjusted multinomial logistic regression models were 
used to assess the association between the outcome 
(multimorbidity classes, with the ‘healthy’ class as the 
reference category) and several variables: loneliness, 
ever smoked, physical activity, limitations in ADL, self- 
rated health, immediate recall, delayed recall and verbal 
fluency. The model was additionally adjusted for sex, age, 
marital status, education level, wealth and the region at 
baseline. Due to potential collinearity between income 
and education, we checked the significance and magni-
tude of the correlation between both variables. The asso-
ciation was small, and thus, both covariates were included 
as separate variables in the models. Regression models 
were conducted separately in 100 imputed datasets and 
results combined using Rubin’s rules.35
All analyses were conducted with Stata SE V.13.1. LCAs 
were performed using a Stata plugin.30
RESULTS
Descriptive analysis
In table 1, the main characteristics of the sample by 
region are presented. The mean age ranged from 62 
years (SD=9.02) in Southern Asia to 65 years (10.18) in 
Russia and 65 years (10.26) in England. Some 54% were 
women, 72% were married or cohabitating, and 39% 
had secondary education. Russia presented the highest 
number of conditions (mean 1.66) compared with Africa 
(0.64), China (0.80) and India (0.72).
The most prevalent conditions in the total sample were 
hypertension (31.2%, 95% CI=30.9% to 31.6%) and joint 
disorders (22.4%, 95% CI=22.0% to 22.7%). Hypertension 
was particularly high in Russia (56.5%, 95% CI=54.9% to 
58.1%) compared with the other regions. Diabetes prev-
alence was greater in Southern (11.9%, 95% CI=11.2% 
to 12.7%) and Western Europe (10.4%, 95% CI=9.9% to 
10.9%), whereas Africa and China presented the lowest 
proportions. Similarly, myocardial infarction–angina 
was highly prevalent in Russia (33.1%, 95% CI=31.6% to 
34.6%), followed by countries of Northern (13.8%, 95% 
CI=12.8% to 14.8%), Southern (11.7%, 95% CI=11.0% 
to 12.4%) and Western Europe (13.1%, 95% CI=12.6% 
to 13.6%).
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Joint disorders were more prevalent in Russia (35.2%, 
95% CI=33.7% to 36.7%) and England (32.5%, 95% 
CI=31.6% to 33.3%). The prevalence of asthma was 
greater in England than other regions (11.7%, 95% 
CI=11.1% to 12.3%) and chronic lung disease was greater 
in Russia (17.9%, 95% CI=16.8% to 19.2%).
As for the prevalence of depression, European coun-
tries presented the highest values, especially in Southern 
(31.7%, 95% CI=30.6% to 32.7%) and Western Europe 
(25.0%, 95% CI=24.3% to 25.6%), whereas LMICs 
showed very low proportions, especially in China, where 
only 1.2% of people aged 50+ years presented depression.
Multimorbidity patterns
Table 2 displays the aBIC, CAIC and entropy values, 
proportions and average posterior probability of each 
latent class, for a two- class to five- class model in both age 
subsamples. In the younger subsample (50–64 years), 
the five- class solution yielded the lowest aBIC and CAIC 
values and the highest entropy value (0.67). However, it 
was dismissed because one of the latent classes was very 
infrequent and the posterior probabilities were far below 
0.70. Similarly, the four- class model was rejected for an 
inadequate posterior probability value in one of the 
classes (0.52). The model finally selected was the three- 
class model. The three- class solution was also chosen for 
the older age group because of lower posterior proba-
bility values in the four- class and five- class models in spite 
of lower aBIC and CAIC values.
We named each latent class according to the most prev-
alent diseases within each latent class. Figure 1 shows the 
distribution of each condition across the three latent 
classes (‘cardio- metabolic’, ‘respiratory- mental- articular’ 
and ‘healthy’ class) in the total sample and by regions. 
The ‘cardio- metabolic’ class presented excess preva-
lence of diabetes, hypertension, myocardial infarction or 
angina and stroke, comprising 8.93% of the total sample 
in the younger group and 27.22% in the older group. 
The ‘respiratory- mental- articular’ class, which comprised 
3.91% and 5.27% of each sample, respectively, showed 
greater prevalence of joint disorders, asthma, chronic 
lung diseases and depression. Finally, the ‘healthy’ class 
presented low prevalence of conditions, comprising 
87.16% of the sample in the first age group and 67.51% 
in the second group.
Differences in the proportions of multimorbidity 
classes were found across regions (figure 1). The ‘cardio- 
metabolic’ class (18.8%, 95% CI=17.1% to 20.6%) was 
significantly greater in Russia than in other regions, and 
England (5.1%, 95% CI=4.5% to 5.7%) showed a higher 
proportion of individuals classified into the ‘respiratory- 
mental- articular’ class. The ‘healthy’ class was higher in 
Africa (91.5%, 95% CI=90.7% to 92.3%), China (90.8%, 
95% CI=90.1% to 91.4%) and India (89.5%, 95% 
CI=88.5% to 90.4%), and remarkably lower in Russia 
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Similar results were found for the older group 
(figure 2). In Russia, the ‘cardio- metabolic’ class was 
significantly higher than in other regions (48.3%, 95% 
CI=46.1% to 50.6%), whereas the ‘healthy’ class was the 
least frequent class compared with the rest of regions 
(38.4%, 95% CI=36.2% to 40.6%), followed by Southern 
Europe (52.6%, 95% CI=50.9 to 54.2). Africa and India 
showed lower proportions of individuals classified into 
the ‘cardio- metabolic’ class (12.9%, 95% CI=11.8% to 
14.1% and 11.2%, 95% CI=10.0% to 12.6%, respectively).
Association between multimorbidity classes and covariates
In the online additional file 2: table S1, the unadjusted 
relative risk ratios (RRRs) for both age subsamples are 
presented. The ‘healthy’ class was used as the refer-
ence group. In the case of the younger subsample, and 
compared with the ‘healthy’ class, individuals classified 
into the ‘cardio- metabolic’ and ‘respiratory- mental- 
articular’ classes were more likely to be older (RRR=1.09, 
95% CI=1.08 to 1.10; RRR=1.06, 95% CI=1.04 to 1.07, 
respectively) and being widowed (RRR=1.4, 95% CI=1.1 
to 1.7) and divorced in the ‘respiratory- mental- articular’ 
class (RRR=1.7, 95% CI=1.2 to 2.4). Being a man, having 
tertiary education and high levels of wealth had a protec-
tive effect for being in both multimorbidity groups 
compared with the ‘healthy’ class. Similarly, those indi-
viduals from the older subsample who were in the fourth 
and fifth quintile (RRR=0.8, 95% CI=0.7 to 1.0) were 
less likely to be classified into the ‘respiratory- mental- 
articular’ class compared with the ‘healthy’ group.
Regarding the association of regions and multimor-
bidity groups, some differences were found in the younger 
subsample. Taking Africa as the reference category, 
participants from Russia were more likely to be classified 
into the ‘cardio- metabolic’ class (RRR=3.6, 95% CI=3.0 to 
4.2), whereas individuals from England (RRR=5.6, 95% 
CI=4.1 to 7.7), Northern Europe (RRR=2.8, 95% CI=1.9 
to 4.1) and India (RRR=2.2, 95% CI=1.5 to 3.2) showed 
higher risk of being in the ‘respiratory- mental- articular’ 
class. In the case of the older subsample, all regions 
had greater risk of being classified into the ‘respiratory- 
mental- articular’ class compared with the ‘healthy’ class, 
especially participants from Russia (RRR=14.5, 95% 
CI=10.3 to 20.3) compared with Africa.
Table 3 shows the adjusted RRRs for both age subsam-
ples, taking the ‘healthy’ class as the reference group. Both 
multimorbidity classes (cardio- metabolic and respiratory- 
mental- articular) were associated with all the covariates 
in the younger group, except for smoking status in the 
‘cardio- metabolic’ class.
In the younger individuals subsample, both latent 
classes were more likely to be associated with the pres-
ence of feelings of loneliness (RRR=1.8, 95% CI=1.7 to 
2.0; RRR=2.5, 95% CI=2.0 to 3.0), limitations in ADL 
(RRR=3.2, 95% CI=2.9 to 3.6; RRR=3.9, 95% CI=3.3 to 
4.7) and worse health status (RRR=12.8, 95% CI=11.3 to 
14.4; RRR=12.9, 95% CI=10.5 to 16.0). Physical activity 
had a protective effect for being in these classes and 
having smoked was a risk factor only for being classified 
into the ‘respiratory- mental- articular’ class (RRR=1.5, 
95% CI=1.2 to 1.7). Conversely, those older individuals 
who had ever smoked had a higher risk of being in the 
‘respiratory- mental- articular’ group (RRR=1.8, 95% 
Table 2 Comparison between models in individuals aged 50–64 and +65 years



















probabilityaBIC CAIC Entropy aBIC CAIC Entropy
2 1512.91 1583.94 0.51 33 023 (82.15) 0.88 1603.3 1674.33 0.39 21 113 (66.10) 0.83
7177 (17.85) 0.75 10 827 (33.90) 0.75
3 875.23 983.86 0.63 3589 (8.93) 0.76 1032.83 1141.46 0.5 8693 (27.22) 0.71
1571 (3.91) 0.67 1684 (5.27) 0.68
35 040 (87.16) 0.87 21 563 (67.51) 0.81
4 777.14 923.37 0.43 25 701 (63.93) 0.52 817.6 963.83 0.63 9557 (29.92) 0.65
626 (1.56) 0.72 1474 (4.61) 0.78
7754 (19.29) 0.8 17 220 (53.91) 0.86
6119 (15.22) 0.68 3689 (11.55) 0.77
5 661.04 844.87 0.67 4578 (11.39) 0.64 689.22 873.05 0.59 11 094 (34.73) 0.77
247 (0.61) 0.67 1094 (3.43) 0.71
32 423 (80.65) 0.85 14 155 (44.32) 0.76
1359 (3.38) 0.48 1148 (3.59) 0.63
1593 (3.96) 0.64 4449 (13.93) 0.72
Boldface indicates the final selected model.
aBIC, adjusted Bayesian Information Criterion; CAIC, consistent Akaike Information Criterion.
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Figure 1 Prevalence of diseases in the three latent classes in the total sample and by regions (subsample 50–64 years). C., 
chronic; MI, myocardial infarction.









pen: first published as 10.1136/bm




8 Bayes- Marin I, et al. BMJ Open 2020;10:e034441. doi:10.1136/bmjopen-2019-034441
Open access 
Figure 2 Prevalence of diseases in the three latent classes in the total sample and by regions (subsample +65 years). C., 
chronic; MI, myocardial infarction
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CI=1.5 to 2.0) and a lower risk of being classified into the 
‘cardio- metabolic’ class (RRR=1.0, 95% CI=0.9 to 1.0). 
For both age subsamples, better performance in verbal 
memory was significantly associated with less risk of being 
classified into the two multimorbidity classes. Similarly, 
higher scores in verbal fluency were a protective factor 
for multimorbidity compared with the healthy individuals 
group.
DISCUSSION
To the best of our knowledge, this is the first multire-
gion study to use harmonised data to compare multi-
morbidity patterns across different regions from three 
distinct population- based cohorts. We identified three 
latent classes of multimorbidity based on the presence 
of eight NCDs: the ‘cardio- metabolic’, the ‘respiratory- 
mental- articular’ and the ‘healthy’ class. The same clus-
ters were identified in another study using SAGE original 
data, applying exploratory factor analysis in a sample of 
41 909 individuals aged 50 years or older.36 Similarly, a 
study of a representative sample of Spanish community- 
dwelling adults over 50 years old also found three latent 
classes using 11 CCs, showing similar disease distributions 
among the multimorbidity clusters.37
In our study, for both age groups the majority of the 
sample was classified into the ‘healthy’ class, 87.16% and 
67.51%, respectively. This latent group has previously 
been described in studies which applied LCA.11 13 37 38 
Likewise, the other two identified classes are similar to 
those reported in a systematic review based on 14 studies 
of multimorbidity patterns.39 In this review, the most 
prevalent diseases in the ‘cardio- metabolic’ group were 
diabetes, hypertension, heart diseases, hyperlipidaemia 
and obesity; and in the second group conditions such as 
mental disorders, thyroid disease, neurological disease, 
pain, asthma or chronic lung diseases, musculoskeletal 
disorders, obesity and gastro- oesophageal reflux disease 
were included. Despite the fact that we included a smaller 
number of diseases, we found analogous patterns. In 
our study, 8.93% of the younger group (50–64 years) 
and 27.22% of the older were classified into the ‘cardio- 
metabolic’ class, including individuals with higher preva-
lence of diabetes, hypertension, myocardial infarction or 
angina, and stroke. This clustering of diseases is similar to 
the metabolic syndrome, which has metabolically related 
cardiovascular risk factors and greater risk of stroke 
and diabetes.40 Lastly, the least prevalent group was the 
‘respiratory- mental- articular’ class, consisting of greater 
prevalence of joint disorders, asthma, chronic lung 
diseases and depression. Association between depression 
and arthritis has commonly been reported, with socioeco-
nomic and disease factors reported as being involved in 
its association, as well as systemic inflammation mecha-
nisms.3 Nevertheless, the links between depression and 
chronic lung diseases, and chronic lung diseases and 
arthritis, despite having been studied, remain unclear.40 41
Analogous latent multimorbidity classes have been 
found among both age groups. Despite this, certain 
aspects should be pointed out. As expected, the propor-
tion of participants classified into the ‘healthy’ class 
was greater in participants aged 50–64 years (87.16%) 
compared with those aged +65 years (67.51%), illustrating 
higher multimorbidity in elderly individuals. The distri-
bution of CCs was also less clear in the older subsample. 
Table 3 Association between latent multimorbidity membership and outcomes in individuals aged 50–64 and ≥65 years
Variables*









Loneliness (yes/no) 1.8 (1.7 to 2.0) 2.5 (2.0 to 3.0) 1.3 (1.2 to 1.5) 1.9 (1.7 to 2.3)
Ever smoked (yes/no) 1.1 (1.0 to 1.2) 1.5 (1.2 to 1.7) 1.0 (0.9 to 1.0) 1.8 (1.5 to 2.0)
Physical activity (yes/no) 0.4 (0.4 to 0.5) 0.5 (0.5 to 0.6) 0.5 (0.5 to 0.6) 0.4 (0.4 to 0.5)
Limitations in ADL (yes/no) 3.2 (2.9 to 3.6) 3.9 (3.3 to 4.7) 2.3 (2.1 to 2.5) 4.0 (3.5 to 4.6)
Self- rated health
  Good 1 1 1 1
  Moderate 4.8 (4.3 to 5.2) 3.9 (3.2 to 4.7) 3.1 (2.9 to 3.4) 5.7 (4.8 to 6.8)
  Poor 12.8 (11.3 to 14.4) 12.9 (10.5 to 16.0) 6.2 (5.6 to 6.9) 19.4 (16.2 to 23.4)
  Memory: Immediate recall 0.9 (0.9 to 0.9) 0.9 (0.9 to 1.0) 0.9 (0.9 to 0.9) 0.9 (0.9 to 1.0)
  Memory: Delayed recall 0.9 (0.9 to 0.9) 0.9 (0.9 to 1.0) 0.9 (0.9 to 0.9) 0.9 (0.9 to 1.0)
  Verbal fluency 1.0 (1.0 to 1.0) 1.0 (1.0 to 1.0) 0.9 (0.9 to 1.0) 1.0 (1.0 to 1.0)
The reference group for the multimorbidity group variable was the ‘healthy’ class.
Relative risk ratios (95% CI) from multinomial logistic regression models.
Models were run in 100 imputed datasets and results combined using Rubin’s rules.
*Adjusted for sex, age, marital status, education level, wealth and region.
ADL, activities of daily living.
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For example, both joint disorders and angina–myocardial 
infarction were similarly present in the ‘cardio- metabolic’ 
and ‘respiratory- mental- articular’ categories, whereas 
in the younger participants (50–64 years) subsample we 
observed a more differentiated profile of those CCs that 
cluster into one latent class. For example, respiratory- 
related diseases (asthma, chronic lung diseases) are highly 
presented in the ‘respiratory- mental- articular’ class, while 
very infrequent among middle- aged people classified 
into the ‘cardio- metabolic’ group. It is worth mentioning 
that although depression is frequently observed among 
participants classified into the ‘respiratory- mental- 
articular’ class, it is not infrequent among people within 
the ‘cardio- vascular’ class. This may be due to the rela-
tionship between mental and physical disorders, which 
has frequently been reported, suggesting a bidirectional 
association between them.42 On the one hand, medical 
conditions could be accompanied by a high symptom 
burden, leading to depression, and, on the other, depres-
sion could be a risk factor for medical conditions, since 
depressive symptoms could increase the incidence of 
behaviours, such as smoking, alcohol intake, poor diet or 
physical inactivity, which are risk factors for NCDs.3 42
One important implication of our findings is the rela-
tively high proportion of people aged 50–64 years with 
multimorbidity. Thus, preventive and intervention 
programmes are also needed for this population to miti-
gate the multimorbidity burden.
Our results show that these multimorbidity patterns 
are qualitatively different, but only when compared with 
the ‘healthy’ class in terms of sociodemographic and 
economic characteristics, lifestyles and health status vari-
ables. As has been reported in the literature, being older, 
woman, widowed, with a lower level of education and 
lower socioeconomic status are related to an increased 
risk of multimorbidity.3 In addition, those individuals 
with multiple CCs were more likely to have limitations 
in ADL, especially those classified into the ‘respiratory- 
mental- articular’ group, similar to what was found in 
another study of multimorbidity.37 Physical activity 
seems to be a protective factor for being classified into 
the ‘respiratory- mental- articular’ class, whereas smokers 
were more likely to be classified into the ‘respiratory- 
mental- articular’ class, but not the ‘cardio- metabolic’ 
class. This is inconsistent with the literature, since ciga-
rette smoking is considered a major cause of cardiovas-
cular diseases (CVDs). However, smoking is probably 
the most complex and least understood risk factor for 
CVDs.43
One interesting finding is the association between 
cognition outcomes and multimorbidity in both age 
subsamples. Better performance in verbal memory and 
fluency was related to less risk of being classified into 
the multimorbidity groups, with similar results among 
latent classes. Impaired cognition has been associated 
with conditions such as arthritis,44 depression45 and respi-
ratory diseases,46 cardiovascular conditions, diabetes,47 
hypertension48 and coronary heart diseases.49
Concerning the regional distribution of multimorbidity, 
Russia accounted for the highest burden as opposed to 
Africa, China and India. The ‘cardio- metabolic’ class is 
especially common in this country, with a prevalence of 
18.82% in the younger and 48.34% in the older subsample. 
Prevalence of CVDs, such as hypertension, myocardial 
infarction or angina, and stroke, was also higher in Russia. 
This high proportion could be related to the high rate of 
alcohol consumption and rapid societal changes experi-
enced in this country, which might account for increased 
risk of circulatory diseases.50 51 Followed by Russia, Euro-
pean regions showed higher rates of multimorbidity. 
NCDs such as hypertension, joint disorders, respiratory 
diseases and depression were highly prevalent, especially 
in England and Southern Europe, where the ‘respiratory- 
mental- articular’ class was highly prevalent in both age 
subsamples. The relationship between mood disorders 
such as depression and joint disorders has been previously 
reported in other studies, though the underlying cause 
remains unclear.36 37 39 Notwithstanding, previous studies 
suggested that the emotional burden of joint disorders 
may contribute to the onset of psychiatric disorders.36 52
LMICs such as Africa, China and India showed lower 
rates of multimorbidity compared with Russia and other 
HICs. However, there was a wide variation in terms of 
some diseases, such as respiratory diseases and depres-
sion. Asthma and chronic lung diseases were highly prev-
alent in India and China, influenced by factors such as 
increasing smoking rates, air pollution and occupational 
lung diseases in these countries.53 As reported in previous 
studies,54 depression was remarkably prevalent in India, 
whereas the lowest prevalence was observed in China. 
This is in line with previous epidemiological studies on 
the prevalence of depression in Chinese older people, 
suggesting differences in diagnostic criteria that make 
depression less diagnosed; somatic symptoms are more 
prevalent in this population instead of sadness, and 
lack of interest and energy. Moreover, stigma and prej-
udice in Chinese population might also contribute to 
under- reporting depressive symptoms.55 56 Furthermore, 
the variation found across regions in terms of depres-
sion prevalence could be due to cultural differences in 
expressions or expectations of mood disorders or mental 
health.57
The highest burden of multimorbidity in HICs could 
be explained by an increased level of development in the 
HICs. Notwithstanding, LMICs are experiencing a change 
in lifestyle and environmental exposures, which contrib-
utes, as in HICs, to multimorbidity. Thus, the increased 
burden of NCDs, in addition to the existing burden of 
infectious diseases such as HIV/AIDS, worsens multimor-
bidity management.3 Moreover, the differences found 
in the regional distribution of multimorbidity might be 
linked to different stages of development of their health 
systems, since there are differences between LMICs and 
HICs in terms of opportunities and barriers to improving 
the organisation, integration and delivery of multimor-
bidity care.3
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Strengths and limitations
A major strength of this study is the use of a large, harmon-
ised, multiregional database. Research on multimorbidity 
has typically been hampered by several factors, such as 
the exclusion of patients with multimorbidity from partic-
ipation, targeting of research mostly on elderly individ-
uals and a shortage of studies focusing on LMICs. The 
ATHLOS study allowed us to compare two age groups 
(50–64 and 65 years or older) as well as disease preva-
lence and clusters of conditions in regions with differing 
incomes in a very large, diverse population- based study of 
middle- aged and older adults.
Some limitations should be considered when inter-
preting our findings. First, the presence or absence of 
the NCDs was based on self- reported measures, and thus 
might be affected by measurement errors or lack of accu-
racy. Nevertheless, some authors sustain self- reported 
diagnostics as a well- established method for the measure-
ment of multimorbidity in population- based studies.58 
Second, participants with an incipient neurodegenerative 
disease may have been included in our analytical sample. 
However, we excluded those participants who completed a 
proxy interview due to cognitive problems, such as neuro-
degenerative diseases, which could affect the reliability 
of the data. Nonetheless, participants with an incipient 
neurodegenerative disease may have been included in 
our analytical sample because of the lack of strong diag-
nostic criteria for dementia in the included studies. Third, 
we could only focus on those diseases that were common 
across studies. Conditions such as obesity, cancer, kidney 
disease and neurological illness were not evaluated. This 
might have led to a smaller number of latent classes or 
to different patterns of multimorbidity. Fourth, when 
performing LCA, the three- class solution was forced. In 
order to determine whether the latent classes were equiv-
alent, invariance analysis should have been performed.59 
Nevertheless, this solution was forced as we aimed to do 
comparisons among age subsamples and regions in terms 
of disease prevalence as well as protective and risk factors. 
Finally, the use of multiple imputations could carry some 
bias. Despite this, the use of multiple imputation proce-
dures is widely advocated when missing data occur in one 
or more covariates in a regression model and under an 
MAR assumption.60 61
The results of this study suggest that NCDs cluster 
together in non- random associations across several 
regions worldwide. The three qualitatively distinct enti-
ties are also linked to several sociodemographic and 
economic characteristics, lifestyles and health status vari-
ables. A deeper understanding of the interactions across 
regions and the studied variables is needed. Knowledge 
regarding broad patterns of conditions may contribute 
to the creation and implementation of guidelines that 
consider clusters of conditions instead of single diseases, 
since multimorbidity has become an unavoidable reality. 
Future efforts should focus on the underlying mecha-
nisms of these clusters as well as their stability over time 
using longitudinal data. Moreover, cohort and age effects 
should be explored as might influence the likelihood of 
reporting some diagnosis and hence result in different 
multimorbidity patterns.
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